Alan Tackett, PhD, Professor of Biochemistry and Molecular Biology Deputy Director of Winthrop P. Rockefeller Cancer Institute, and Scharlau Family Endowed Chair for Cancer Research at UAMS College of Medicine, discusses research he led on a key driver of cancer cell development.
This week, Psychiatric Times asked their contributors the following question: “Why don't we hear about the opioid crisis in America anymore? Did it go away during COVID?" Mental health professionals agree: the opioid crisis needs to be a priority.
Linda Spaulding RN-BC, CIC, CHEC, CHOP, is an infection preventionist and a consultant who helps hospitals and other health care systems (but mostly hospitals) solve their infection prevention problems. At the beginning of the COVID-19 pandemic in March 2020, IPs were not only respected, they were the much-sought-after experts whom other health care professionals turned to when they had questions about how best to protect their patients and themselves from SARS-CoV-2. Flash forward some 20 months and IPs are once more being treated as the step-children in health care, says Spaulding.
Ketamine assisted therapies are an emergent treatment option for a number of mental health conditions, including major depression and addiction. However, regulations and best-practices are still uncertain, and the future of ketamine-based treatment is still unknown. In this series, pharmacists discuss their view of the current challenges facing ketamine therapy and speculate on the future of the practice.
Una Lee, MD, and Wai Lee, MD, discuss the outcomes of a study examining the perspectives of urological surgeons on mid-urethral sling (MUS) surgery for women with stress incontinence.
As the pandemic laid bare disparities in social determinants of health and health equity, employers have been tasked with reforming health policies that historically overlooked preventive care and public health services. A panel of experts from Midwest Business Group on Health and Huron addressed how these organizations can better integrate preventive services in their health and benefit strategies, as well as address other care needs that grew in prominence amid COVID-19.
The COVID pandemic is driving interest in the importance of the immune system to human health, and platform technologies to preventing and treating disease. There are roughly 60 million patients in western society dealing with immune mediated diseases. Tackling drug development through a pathway approach opens the potential to treat multiple diseases with one therapy. New ongoing research by Janssen Immunology continues to validate their “pipeline in a pathway” model to treating immune mediated diseases in multiple therapeutic areas including psoriasis, psoriatic arthritis, Crohn’s, ulcerative colitis and more.
Indicative of her selfless nature, Dr. Hernandez-Trujillo has personally dealt with the COVID-19 pandemic by remaining stalwart in her dedication to informing patients and caregivers about the complications of food allergy. Additionally, she has spent much time caring for her family which includes her two daughters, both of whom are affected by food allergies.
Shane Bishop, pharmacist and Pack4U founder, discusses how Pack4U has created a pharmacy network, making it easier for pharmacies to deliver medications and provide personalized care within their communities. He dives into the $500 billion dollar medication adherence issue that exists and discusses innovative patient-care models and the use of technology to improve adherence, patient health outcomes and quality measures.
Communication between health care providers and their patients are critical during patient appointments, but the communication outside of those appointments is just as critical both for the health of the patient and the success of the practice. We spoke with Serge Longin, co-founder and CEO of RevenueWell, a digital communications provider for dental practices, who shared insights on how to connect with patients in ways that meet the needs of both patients and practices, as well as the benefits of newer technologies that enable more flexible communications without sacrificing privacy or security.
Michael Hogue and Jacinda C. Abdul-Mutakabbir sat down to discuss the importance of trust when tackling the issue of vaccine hesitancy, especially among communities of color. During the discussion, Hogue and Abdul-Mutakabbir discussed how teams from Loma Linda University went door-to-door inviting patients to receive COVID-19 vaccines, demonstrating the importance of a personal connection. They also discussed how vaccine hesitancy could differ when it comes to booster vaccines.
During the 2021 European Society of Medical Oncology Congress, multiple presentations took a closer look at toxicity to answer clinical questions of whether certain drugs lead to a high occurrence of key adverse events and how oncologists can take some inevitable toxicities into consideration when deciding on treatment for their patients.
Dr. Anthony W. Tolcher, of NEXT Oncology and Texas Oncology, and Dr. Alexander I. Spira (SPY-RA), of the Virginia Cancer Specialist Research Institute and the Phase 1 Trial Program, join Inside the Practice to discuss a new partnership that will allow more patients to enroll to phase 1 trial. NEXT Oncology and the Phase 1 Trial Program of Virginia Cancer Specialists have come together to give patients who have tried multiple other lines of therapy another chance at successful cancer treatment. In the interview, Tolcher and Spira discuss what they hope will come out of this partnership and where they see potential moving forward.
A panel of infection preventionists were asked: Has the COVID-19 pandemic presented unique challenges to infection preventionists regarding protecting patients from health care-acquired infections?
Dr. William Schaffner chatted at the inflection point of COVID-19 vaccine booster dose regulation: the Vaccines and Related Biologic Products Advisory Committee (VRBPAC) had just given unanimous support to Moderna’s and Johnson & Johnson’s booster dose applications, and the FDA was days away from revamping the eligibility and availability of those doses and the already emergency-authorized dose from Pfizer-BioNTech.
In this interview, we explore how the FDA box warning given to certain JAK inhibitors after study results on tofacitinib were released. We talked to multiple dermatologists about their thoughts on this warning. We wanted to know how this will affect the drug pipeline, and how dermatologists should explain the situation to their patients.
Sumair Akhtar, chief clinical officer at Livio Health, and John Park, the company’s chief growth officer explore palliative care, the differences between palliative care and hospice, and some of the obstacles to providing palliative care to patients who need it.
Dr. Erin Jospe is a board-certified physician and remains clinically active with 20+ years of experience. She earned her MD from The John Hopkins School of Medicine, and completed clinical training at Beth Israel Deaconess Medical Center and Harvard Medical School. Dr. Jospe discusses how consumer access preferences have changed throughout the pandemic and what independent practices can respond to these changing demands.
Experts in the oncology community discusses disparities in cancer care.
Many medical professionals still believe in the stigma of medical cannabis use. Oftentimes, a personal experience is the only thing that will ultimately change a person’s perspective on medical cannabis. Nique Pichette, MSN, RN, falls into this category. She was against cannabis until she had a recurrence of breast cancer and was left with little other treatment options. Now in remission, Nique believes in the benefits of medical cannabis for a variety of illnesses and helps educate the medical community. Our discussion talks about her personal journey, the way it impacted her nursing career, her current role as a nurse seeking higher education for medical cannabis, and more.
Not everyone who studies the techniques used in the dental industry goes on to have a career fixing people’s teeth. For make-up artist Matt Turull, learning the skills of a dental lab technician was a pathway to creating better teeth for his work doing make-up for movie and TV productions. He joins Dental Products Report editorial director Noah Levine to discuss the “theatrical dentistry” work he does using the materials and techniques of a dental lab to craft teeth that help actors and actresses embody their characters, whether they need a distinctive gap in an otherwise normal smile, or sharp fangs while playing an otherworldly monster.
Michael Krychman and Alyssa Dweck discuss the North American Menopause Society’s 2021 Annual Meeting, the latest menopause products, and more.
Lisa Faast, CEO of DiversityRx, offers her marketing expertise to discuss easy, actionable, and effective ways that pharmacies can leverage Halloween to boost visibility and engage customers. Jane Nicholson, owner of Mahaska Drug, discusses the impressive Halloween events that her community pharmacy is hosting this year. Joe Moose, owner of Moose Pharmacy, talks about how his staff get into the Halloween spirit and the importance of pharmacies engaging with their surrounding communities. Nancy Brace highlights the Halloween-themed events at Medicap Pharmacy and the uplifting feedback from patients.
As social determinants of health became further exacerbated by the COVID-19 pandemic, findings of ShareCare’s Community Well-Being Index highlighted the significant differences in health outcomes present in rural and urban areas. In the interview, Elizabeth Colyer, senior vice president of ShareCare, discusses these findings and further considerations for managing community well-being of affected communities.
Sarah Jackson speaks on how her dermatology practice has to prepared for hurricanes such as Hurricane Ida. She describes how her past experiences influences her current preparedness protocol and the details of how she protects important business documents and treatments.
Raymond U. Osarogiagbon, MD, an oncologist at Baptist Cancer Center, discusses disparities in lung cancer care in the United States.
Fifty years in - CT remains a cornerstone of medical imaging, aiding not only in diagnosis of disease or trauma, but also in helping to plan and guide therapeutic interventions as well as monitor their outcomes. Diagnostic Imaging spoke with Cynthia H. McCollough, PhD, to discuss how CT is currently utilized and highlighted the many ways we can optimize its use in different clinical scenarios, especially when taking into account the technology that allows us to personalize the experience for each patient.
On this episode of Second Opinion, Josh Herrman, AIA, DBIA, vice president of design at Hutton; Matt Byrum, AIA, LEED AP, architectural team lead at Hutton; and Jennifer Szambecki, MBA, CPM, marketing director at Hutton sat down with dvm360 to discuss design build—their preferred project method delivery when remodeling or building a veterinary hospital. They shared why they are in favor of design build, debunked common myths associated with it, plus provided more tips on ensuring a successful experience.
In this segment, clinicians practicing in cardiology offer their perspective on how to best identify and avoid clinical inertia in their own practices.
Dr. Mitzi Joi Williams, a board-certified neurologist and MS specialist based in Atlanta, Georgia, offered her perspective on the unique aspects of care when it comes to treating millennial patients with multiple sclerosis. She spoke to their differences from older generations in understanding their disease and their desire to be involved in the decision-making process when it comes to disease-modifying therapies and care goals.
